These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 15565917

  • 1. Irinotecan combined with bolus 5-fluorouracil and folinic acid for metastatic colorectal cancer: is this really a dangerous treatment?
    Idelevich E, Man S, Lavrenkov K, Gluzman A, Geffen DB, Shani A.
    J Chemother; 2004 Oct; 16(5):487-90. PubMed ID: 15565917
    [Abstract] [Full Text] [Related]

  • 2. Retrospective comparison of two different schedules of irinotecan, 5-fluorouracil and folinic acid in previously untreated patients with advanced colorectal carcinoma: a single institution experience.
    Gluzman A, Rubinov K, Mermershtain W, Man S, Ariad S, Lavrenkov K.
    J Chemother; 2007 Dec; 19(6):739-43. PubMed ID: 18230559
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]

  • 4. Irinotecan, oxaliplatin plus bolus 5-fluorouracil and low dose folinic acid every 2 weeks: a feasibility study in metastatic colorectal cancer patients.
    Martinez J, Martin C, Chacon M, Korbenfeld E, Bella S, Senna S, Richardet E, Coppola F, Bas C, Hidalgo J, Escobar E, Reale M, Smilovich AM, Wasserman E.
    Am J Clin Oncol; 2006 Feb; 29(1):45-51. PubMed ID: 16462502
    [Abstract] [Full Text] [Related]

  • 5. Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer.
    Glimelius B, Ristamäki R, Kjaer M, Pfeiffer P, Skovsgaard T, Tveit KM, Linné T, Frödin JE, Boussard B, Oulid-Aïssa D, Pyrhönen S.
    Ann Oncol; 2002 Dec; 13(12):1868-73. PubMed ID: 12453854
    [Abstract] [Full Text] [Related]

  • 6. An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial.
    Ferrari V, Valcamonico F, Amoroso V, Simoncini E, Vassalli L, Marpicati P, Rangoni G, Grisanti S, Pasinetti N, Marini G.
    Oncology; 2005 Dec; 69(4):283-9. PubMed ID: 16282707
    [Abstract] [Full Text] [Related]

  • 7. A randomised phase II study of irinotecan in combination with 5-FU/FA compared with irinotecan alone as second-line treatment of patients with metastatic colorectal carcinoma.
    Graeven U, Arnold D, Reinacher-Schick A, Heuer T, Nusch A, Porschen R, Schmiegel W.
    Onkologie; 2007 Apr; 30(4):169-74. PubMed ID: 17396039
    [Abstract] [Full Text] [Related]

  • 8. Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.
    Hartmann JT, Oechsle K, Jäger E, Reis HE, Haag C, Niederle N, Wilke HJ, Pflüger KH, Batran SA, Büchele T, Hofheinz RD, Kanz L, Bokemeyer C.
    Anticancer Drugs; 2004 Jun; 15(5):473-7. PubMed ID: 15166621
    [Abstract] [Full Text] [Related]

  • 9. Phase I study of CPT-11 and bolus 5-FU/ l-leucovorin in patients with metastatic colorectal cancer.
    Fujishima H, Kikuchi I, Miyanaga O, Ueda A, Baba E, Mitsugi K, Harada M, Nakano S.
    Int J Clin Oncol; 2004 Apr; 9(2):92-7. PubMed ID: 15108040
    [Abstract] [Full Text] [Related]

  • 10. Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer.
    Goto A, Yamada Y, Hosokawa A, Ura T, Arai T, Hamaguchi T, Muro K, Shimada Y, Shirao K.
    Int J Clin Oncol; 2004 Oct; 9(5):364-8. PubMed ID: 15549585
    [Abstract] [Full Text] [Related]

  • 11. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
    Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts S.
    J Clin Oncol; 2006 Jul 20; 24(21):3347-53. PubMed ID: 16849748
    [Abstract] [Full Text] [Related]

  • 12. A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer.
    Van Cutsem E, Pozzo C, Starkhammar H, Dirix L, Terzoli E, Cognetti F, Humblet Y, Garufi C, Filez L, Gruia G, Cote C, Barone C.
    Ann Oncol; 1998 Nov 20; 9(11):1199-204. PubMed ID: 9862050
    [Abstract] [Full Text] [Related]

  • 13. Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo Clinic regimen in the first-line therapy of advanced colorectal cancer.
    Graeven U, Ridwelski K, Artandi M, Espana P, Schölmerich J, Rosales AM, Carlsson G, Borner M, Boussard B, Schmiegel W.
    Oncol Rep; 2005 Apr 20; 13(4):681-8. PubMed ID: 15756442
    [Abstract] [Full Text] [Related]

  • 14. Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.
    Teufel A, Steinmann S, Siebler J, Zanke C, Hohl H, Adami B, Schroeder M, Klein O, Höhler T, Galle PR, Heike M, Moehler M.
    BMC Cancer; 2004 Jul 20; 4():38. PubMed ID: 15265233
    [Abstract] [Full Text] [Related]

  • 15. Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group.
    Comella P, Crucitta E, De Vita F, De Lucia L, Farris A, Del Gaizo F, Palmeri S, Lannelli A, Mancarella S, Tafuto S, Maiorino L, Buzzi F, De Cataldis G, Associated Institutions of the Southern Italy Cooperative Oncology Group.
    Ann Oncol; 2002 Jun 20; 13(6):866-73. PubMed ID: 12123331
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G, Tucci A, Rinaldi A, Colarusso D, Pizza C, Reggiardo G, Manzione L.
    Oncology; 2004 Jun 20; 66(5):371-8. PubMed ID: 15331924
    [Abstract] [Full Text] [Related]

  • 17. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A.
    J Clin Oncol; 1996 Aug 20; 14(8):2274-9. PubMed ID: 8708717
    [Abstract] [Full Text] [Related]

  • 18. Modified-irinotecan/fluorouracil/levoleucovorin therapy as ambulatory treatment for metastatic colorectal cancer: results of phase I and II studies.
    Yuuki S, Komatsu Y, Fuse N, Kato T, Miyagishima T, Kudo M, Watanabe M, Tateyama M, Kunieda Y, Wakahama O, Sakata Y, Asaka M.
    Clin Drug Investig; 2010 Aug 20; 30(4):243-9. PubMed ID: 20225907
    [Abstract] [Full Text] [Related]

  • 19. Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.
    Köhne CH, van Cutsem E, Wils J, Bokemeyer C, El-Serafi M, Lutz MP, Lorenz M, Reichardt P, Rückle-Lanz H, Frickhofen N, Fuchs R, Mergenthaler HG, Langenbuch T, Vanhoefer U, Rougier P, Voigtmann R, Müller L, Genicot B, Anak O, Nordlinger B, European Organisation for Research and Treatment of Cancer Gastrointestinal Group.
    J Clin Oncol; 2005 Aug 01; 23(22):4856-65. PubMed ID: 15939923
    [Abstract] [Full Text] [Related]

  • 20. Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC).
    Wein A, Siebler J, Wolff K, Ostermeier N, Busse D, Hagel A, Koch F, Merx K, Neurath MF, Hofheinz RD.
    Anticancer Res; 2017 Jul 01; 37(7):3771-3779. PubMed ID: 28668873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.